Latest News in the pharma Industry

Policy & Regulation

TraceLink customers receive EMVO approval for data submission to EU Hub

TraceLink customers receive EMVO approval for data submission to EU Hub

6 Jun 2018

Company has developed a standard feature for its customers to execute the EMVO conformance testing successfully.

Read more 
FDA approves Pfizer's biosimilar Retacrit

FDA approves Pfizer's biosimilar Retacrit

22 May 2018

Retacrit, the first US biosimilar erythropoiesis-stimulating agent, now approved across all indications.

Read more 
Serialisation — looking for value-added opportunities

Serialisation — looking for value-added opportunities

15 May 2018

Recipharm's Staffan Widengren, Director Corporate Projects, discusses why CMOs should be focusing on the value-added opportunities presented by serialisation.

Read more 
Industry’s largest survey on serialization readiness throws up disparity

Industry’s largest survey on serialization readiness throws up disparity

30 Apr 2018

Global Drug Supply, Safety and Traceability Report reveals disparity in industry’s readiness to comply with track and trace regulations in the US and EU.

Read more 
TraceLink unveils EU FMD Express

TraceLink unveils EU FMD Express

11 Apr 2018

Purpose-built compliance solution for smaller pharmaceutical companies.

Read more 
TraceLink's network approach gets pioneering German biotech EU FMD compliant

TraceLink's network approach gets pioneering German biotech EU FMD compliant

1 Mar 2018

biosyn chooses a solution that ensures on-time compliance and delivers the required scalability.

Read more 
Company goes all out to fully support clients

Company goes all out to fully support clients

26 Feb 2018

Gaining GLP/GMP accreditation to provide greater assurance of data integrity for clients looking to take their compounds to IND.

Read more 
Expanded GXP compliance increases Concept's breadth of services

Expanded GXP compliance increases Concept's breadth of services

9 Feb 2018

Successful MHRA inspection at Dundee site confirms GLP accreditation for in vitro safety studies and bioanalysis.

Read more 
'Effective' hair loss treatment candidate advances to Phase IIa

'Effective' hair loss treatment candidate advances to Phase IIa

7 Feb 2018

German Medicines Agency sees potential in FOL-005 - a modified version of the endogenous protein, osteopontin - the green light for further studies.

Read more 
Sanofi, DNDi seek EMA review for sleeping sickness treatment

Sanofi, DNDi seek EMA review for sleeping sickness treatment

1 Feb 2018

Fexinidazole would be first all-oral treatment under investigation for both first and second stages of sleeping sickness, a fatal disease, endemic in Africa.

Read more 
Companies warned for selling unapproved opioid cessation products using deceptive claims

Companies warned for selling unapproved opioid cessation products using deceptive claims

26 Jan 2018

The companies have 15 days to respond to the FDA and FTC.

Read more 
Shire receives FDA approval for tech transfer of Cinryze

Shire receives FDA approval for tech transfer of Cinryze

24 Jan 2018

Commercial manufacturing of Cinryze drug product in Vienna to begin in the first quarter of 2018.

Read more